Logo image of ALSOG.PA

SOGECLAIR (ALSOG.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALSOG - FR0000065864 - Common Stock

25 EUR
+0.2 (+0.81%)
Last: 11/21/2025, 7:00:00 PM
Fundamental Rating

6

ALSOG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 45 industry peers in the Aerospace & Defense industry. ALSOG has an excellent financial health rating, but there are some minor concerns on its profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on ALSOG. These ratings would make ALSOG suitable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year ALSOG was profitable.
ALSOG had a positive operating cash flow in the past year.
ALSOG had positive earnings in 4 of the past 5 years.
In the past 5 years ALSOG always reported a positive cash flow from operatings.
ALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

The Return On Assets of ALSOG (3.53%) is comparable to the rest of the industry.
ALSOG has a Return On Equity of 11.10%. This is comparable to the rest of the industry: ALSOG outperforms 47.73% of its industry peers.
ALSOG has a Return On Invested Capital of 9.75%. This is in the better half of the industry: ALSOG outperforms 63.64% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALSOG is below the industry average of 9.16%.
The last Return On Invested Capital (9.75%) for ALSOG is above the 3 year average (6.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.53%
ROE 11.1%
ROIC 9.75%
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ALSOG.PA Yearly ROA, ROE, ROICALSOG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

Looking at the Profit Margin, with a value of 3.17%, ALSOG is doing worse than 63.64% of the companies in the same industry.
In the last couple of years the Profit Margin of ALSOG has grown nicely.
ALSOG's Operating Margin of 5.80% is on the low side compared to the rest of the industry. ALSOG is outperformed by 68.18% of its industry peers.
In the last couple of years the Operating Margin of ALSOG has grown nicely.
With an excellent Gross Margin value of 59.16%, ALSOG belongs to the best of the industry, outperforming 84.09% of the companies in the same industry.
In the last couple of years the Gross Margin of ALSOG has remained more or less at the same level.
Industry RankSector Rank
OM 5.8%
PM (TTM) 3.17%
GM 59.16%
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
ALSOG.PA Yearly Profit, Operating, Gross MarginsALSOG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40

7

2. Health

2.1 Basic Checks

ALSOG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ALSOG remains at a similar level compared to 1 year ago.
ALSOG has a better debt/assets ratio than last year.
ALSOG.PA Yearly Shares OutstandingALSOG.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
ALSOG.PA Yearly Total Debt VS Total AssetsALSOG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

ALSOG has an Altman-Z score of 2.49. This is not the best score and indicates that ALSOG is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.49, ALSOG is in line with its industry, outperforming 47.73% of the companies in the same industry.
The Debt to FCF ratio of ALSOG is 1.39, which is an excellent value as it means it would take ALSOG, only 1.39 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALSOG (1.39) is better than 88.64% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that ALSOG is not too dependend on debt financing.
The Debt to Equity ratio of ALSOG (0.44) is better than 61.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.39
Altman-Z 2.49
ROIC/WACC1.27
WACC7.67%
ALSOG.PA Yearly LT Debt VS Equity VS FCFALSOG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.66 indicates that ALSOG should not have too much problems paying its short term obligations.
The Current ratio of ALSOG (1.66) is better than 77.27% of its industry peers.
A Quick Ratio of 1.41 indicates that ALSOG should not have too much problems paying its short term obligations.
ALSOG has a better Quick ratio (1.41) than 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.41
ALSOG.PA Yearly Current Assets VS Current LiabilitesALSOG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

ALSOG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.16%, which is quite impressive.
The Earnings Per Share has been growing by 18.82% on average over the past years. This is quite good.
ALSOG shows a small growth in Revenue. In the last year, the Revenue has grown by 2.53%.
Measured over the past years, ALSOG shows a quite strong growth in Revenue. The Revenue has been growing by 9.06% on average per year.
EPS 1Y (TTM)76.16%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%68.09%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%1.85%

3.2 Future

The Earnings Per Share is expected to grow by 18.42% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.01% on average over the next years.
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALSOG.PA Yearly Revenue VS EstimatesALSOG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSOG.PA Yearly EPS VS EstimatesALSOG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.15 indicates a correct valuation of ALSOG.
Compared to the rest of the industry, the Price/Earnings ratio of ALSOG indicates a rather cheap valuation: ALSOG is cheaper than 97.73% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.45, ALSOG is valued a bit cheaper.
A Price/Forward Earnings ratio of 9.63 indicates a reasonable valuation of ALSOG.
ALSOG's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALSOG is cheaper than 100.00% of the companies in the same industry.
ALSOG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.46.
Industry RankSector Rank
PE 15.15
Fwd PE 9.63
ALSOG.PA Price Earnings VS Forward Price EarningsALSOG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALSOG indicates a rather cheap valuation: ALSOG is cheaper than 93.18% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ALSOG is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.99
EV/EBITDA 7.15
ALSOG.PA Per share dataALSOG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALSOG has a very decent profitability rating, which may justify a higher PE ratio.
ALSOG's earnings are expected to grow with 18.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.57
PEG (5Y)N/A
EPS Next 2Y19.67%
EPS Next 3Y18.42%

5

5. Dividend

5.1 Amount

ALSOG has a Yearly Dividend Yield of 3.87%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.20, ALSOG pays a better dividend. On top of this ALSOG pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, ALSOG pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.87%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ALSOG.PA Yearly Dividends per shareALSOG.PA Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

58.45% of the earnings are spent on dividend by ALSOG. This is a bit on the high side, but may be sustainable.
DP58.45%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
ALSOG.PA Yearly Income VS Free CF VS DividendALSOG.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 10M -10M 20M
ALSOG.PA Dividend Payout.ALSOG.PA Dividend Payout, showing the Payout Ratio.ALSOG.PA Dividend Payout.PayoutRetained Earnings

SOGECLAIR

EPA:ALSOG (11/21/2025, 7:00:00 PM)

25

+0.2 (+0.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)10-29 2025-10-29
Earnings (Next)01-27 2026-01-27
Inst Owners4.78%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap80.00M
Revenue(TTM)158.49M
Net Income(TTM)5.03M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.87%
Yearly Dividend0.94
Dividend Growth(5Y)N/A
DP58.45%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.15
Fwd PE 9.63
P/S 0.5
P/FCF 3.99
P/OCF 3.75
P/B 1.77
P/tB 3.26
EV/EBITDA 7.15
EPS(TTM)1.65
EY6.6%
EPS(NY)2.6
Fwd EY10.38%
FCF(TTM)6.27
FCFY25.09%
OCF(TTM)6.68
OCFY26.7%
SpS49.53
BVpS14.16
TBVpS7.68
PEG (NY)0.57
PEG (5Y)N/A
Graham Number22.93
Profitability
Industry RankSector Rank
ROA 3.53%
ROE 11.1%
ROCE 11.29%
ROIC 9.75%
ROICexc 12.06%
ROICexgc 17.44%
OM 5.8%
PM (TTM) 3.17%
GM 59.16%
FCFM 12.66%
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ROICexc(3y)7.41%
ROICexc(5y)N/A
ROICexgc(3y)10.8%
ROICexgc(5y)N/A
ROCE(3y)7.22%
ROCE(5y)N/A
ROICexgc growth 3Y2.87%
ROICexgc growth 5YN/A
ROICexc growth 3Y7.7%
ROICexc growth 5YN/A
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
F-Score8
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.39
Debt/EBITDA 1.61
Cap/Depr 38.54%
Cap/Sales 0.82%
Interest Coverage 9.7
Cash Conversion 170.17%
Profit Quality 398.97%
Current Ratio 1.66
Quick Ratio 1.41
Altman-Z 2.49
F-Score8
WACC7.67%
ROIC/WACC1.27
Cap/Depr(3y)47.93%
Cap/Depr(5y)229.26%
Cap/Sales(3y)2.07%
Cap/Sales(5y)2.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.16%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%68.09%
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue 1Y (TTM)2.53%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%1.85%
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A
EBIT growth 1Y48.74%
EBIT growth 3Y20.81%
EBIT growth 5YN/A
EBIT Next Year132.14%
EBIT Next 3Y38.24%
EBIT Next 5YN/A
FCF growth 1Y978.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y779.78%
OCF growth 3Y101.39%
OCF growth 5YN/A

SOGECLAIR / ALSOG.PA FAQ

What is the fundamental rating for ALSOG stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALSOG.PA.


What is the valuation status for ALSOG stock?

ChartMill assigns a valuation rating of 8 / 10 to SOGECLAIR (ALSOG.PA). This can be considered as Undervalued.


What is the profitability of ALSOG stock?

SOGECLAIR (ALSOG.PA) has a profitability rating of 6 / 10.


Can you provide the financial health for ALSOG stock?

The financial health rating of SOGECLAIR (ALSOG.PA) is 7 / 10.


What is the earnings growth outlook for SOGECLAIR?

The Earnings per Share (EPS) of SOGECLAIR (ALSOG.PA) is expected to grow by 26.7% in the next year.